Real Estate Investor · Austin, TX · Member since 2017 · 142 posts · 35 votes
Looking at a small multifamily where the seller is carrying the note — 30-year amortization, below-market rate, 10% down. Price is a bit above what I'd pay with bank debt, which makes sense given the terms.
My question for the cost seg folks: does seller financing change anything about the study itself?
My understanding is the depreciable basis is still the purchase price (plus closing costs), financed or not — the study allocates that basis across 5/7/15/27.5-year buckets the same way. But two things I'm unsure about:
1. Below-market rate — if the note's rate is under the AFR, imputed interest rules (Sections 1274/483) treat part of the stated principal as interest, which I think means the buyer's basis is the present value of the note, not the face amount. Does that shrink the depreciable basis the study works from?
2. The negotiated price — with seller financing the price often runs high because the terms are doing work. Does that make the land/building allocation harder to defend, or does the study just take the price as given?
Has anyone run a study on a seller-financed deal? Did the financing change the numbers at all, or was it a non-issue once the basis was set?
Sagiv, I work the buyer side of seller-financed deals, so I will leave the tax question to the cost seg folks here. The part I can speak to is the paper. I keep the note, the payment history, and every receipt in one place, because that record is what everything else rests on. I am still learning, and keeping the paper clean is the part I can control.